














of	 deaths	 in	 SMI	 could	 be	 avoided	 if	 patients	 are	 offered	 prompt	 physical	 health	
screening	 for	 known	 risk	 factors.	We	 aimed	 to	 identify	 SMI	 patients	 registered	 at	 a	
General	Practice	and	audit	their	care	in	relation	to	physical	health	monitoring.	
We	included	adult	patients	with	coded	diagnoses	of	SMI.	We	selected	18	best	practice	
criteria	 for	 physical	 health	 monitoring,	 based	 on	 Quality	 and	 Outcomes	 Framework	
(QOF)	 indicators	 for	mental	 health,	NICE	 guidelines	 and	 other	 professional	 guidance.	
Data	 was	 obtained	 from	 electronic	 patient	 records	 and	 examined	 over	 a	 12-month	
period.		
Only	 5	 out	 of	 18	 best	 practice	 criteria	 achieved	 compliance	 above	 the	 expected	
standard	 of	 70%	 (annual	 record	 of	 blood	 pressure,	 smoking,	 alcohol,	 medication	
review,	prescription	on	repeat	template).	Care	planning	achieved	69%;	and	most	of	the	
remaining	 parameters	 (pulse,	 BMI,	 weight,	 QRISK2,	 serum	 lipids,	 glucose,	 dietary	
advice,	 physical	 activity,	 drug	 use)	 reached	 levels	 around	 50-60%.	 Particularly	 low	
compliance	 (<40%)	 was	 found	 for	 ECG,	 pregnancy/contraception	 advice	 and	
medication	side-effects.		
There	 is	 definite	 room	 for	 improvement	 regarding	 physical	 health	monitoring	 of	 SMI	
patients	within	general	practice.	We	recommend	increased	attention	to	annual	physical	
health	 checks,	 particularly	 cardiovascular	 risk	 factors,	 and	 the	 consistent	 offer	 of	













Poor	 physical	 health	 and	 multi-morbidity	 is	 common	 in	 people	 with	 Severe	 Mental	
Illness	 (SMI).	 SMI	 is	 defined	 as	 any	 disorder	 of	 the	 mind	 which	 causes	 debilitating	
psychological	problems	of	a	degree	and	nature	that	the	individual’s	ability	to	engage	in	
functional	 and	 occupational	 activities	 is	 severely	 impaired	 (Public	 Health	 England,	
2018).	Individuals	with	SMI	have	shorter	lifespans	compared	to	those	without	mental	
illness	(Rodgers	et	al.,	2018).	It	is	estimated	that	2	in	3	deaths	in	this	patient	population	
are	 from	physical	 illnesses	 that	 can	be	prevented	 (Mental	Health	Foundation,	2016).	
Thus,	up	to	two-thirds	of	mortality	 in	SMI	 is	avoidable	 if	patients	are	offered	prompt	
physical	health	screening	checks	for	known	health	risk	factors	(Silverwood	et	al.,	2019).		
	
Major	 causes	 of	 mortality	 and	 morbidity	 in	 SMI	 individuals	 have	 been	 linked	 to	
common	 medical	 complications;	 particularly	 smoking-	 and	 obesity-related	
cardiovascular	and	 respiratory	problems,	as	well	as	chronic	physical	 illnesses	 such	as	
diabetes	 and	 hypertension	 (John	 et	 al.,	 2018).	 In	 fact,	 cardiovascular	 disease	 (CVD)	
accounts	 for	40-50%	of	overall	mortality	 in	SMI,	according	to	research	 (Ringen	et	al.,	
2014).	 Metabolic	 syndrome	 (sometimes	 also	 referred	 to	 as	 Syndrome	 X	 or	
Dysmetabolic	 syndrome)	 is	 a	 cluster	 of	 cardiovascular	 risk	 factors	 including	
hypertension,	 abdominal	 obesity,	 dyslipidaemia,	 insulin	 resistance	 and	 glucose	
intolerance.	 The	 rates	 of	metabolic	 syndrome	 are	 reported	 to	 be	 as	 high	 as	 60%	 in	
individuals	with	 SMI	 (Crump	et	 al.,	 2013);	 the	 use	 of	 psychotropic	 agents,	 especially	
antipsychotic	drugs,	 further	 increases	the	 incidence	of	cardiometabolic	risk	 factors	 in	
the	SMI	population	(Shiers	et	al.,	2014).	With	the	rise	in	obesity	and	diabetes	mellitus	
globally,	 a	 parallel	 increase	 in	 rates	 of	 metabolic	 syndrome	 seems	 inevitable.	 A	
complex	 interplay	 of	 aetiological	 factors,	 including	 lifestyle	 and	 environmental	










support	 earlier	 research	 findings	 and	 highlight	 the	 need	 to	 improve	 the	 focus	 on	
physical	health	needs	in	SMI.	The	audit	of	5,091	records	of	people	with	SMI	receiving	
care	 in	 mental	 health	 settings	 in	 England	 and	 Wales,	 found	 that	 the	 frequency	 of	
screening	 and	 monitoring	 interventions	 for	 physical	 health	 needs	 was	 significantly	
lower	 than	 in	 the	 general	 population.	 The	 report	 found	 that	 measures	 for	 weight	
and/or	body	mass	index	(BMI)	had	been	recorded	in	less	than	half	of	the	patients;	and	
that	 interventions	were	 only	 offered	 to	 just	 over	 half	 (54%)	 of	 patients	with	 known	
high	blood	pressure.	Several	national	policies	and	guidance	frameworks	including:	the	
Royal	 College	 of	 Psychiatrists’	 Accreditation	 for	 Inpatient	 Mental	 Health	 Services	
(AIMS;	RCPsych	2019),	Care	Quality	Commission-	physical	health	checks	 in	SMI	 (CQC,	
2017),	the	National	 Institute	for	Health	and	Care	Excellence	(NICE,	2014),	the	Quality	
and	 Outcomes	 Framework	 (QOF;	 NICE	 2019),	 the	 Commissioning	 for	 Quality	 and	
Innovation-	improving	physical	health	for	people	with	SMI	(CQUIN;	NHS	England	2019),	
and	 the	 Lester	 UK	 adaptation	of	 the	 Positive	 Cardiometabolic	 Health	 Resource	 tool	
(Shiers	 at	 al.,	 2014),	 provide	 best	 practice	 recommendations	 for	 improving	 physical	
health	monitoring	and	outcomes	 in	SMI,	 informed	by	current	evidence.	Similarly,	 the	
NHS	Five	Year	Forward	View	for	Mental	Health	and	the	NHS	Long	Term	Plan	for	Mental	




• To	 identify	 all	 patients	 with	 severe	 mental	 illness	 registered	 at	 a	 General	
Practice	 in	 north	 London,	 and	 to	 evaluate	 and	 audit	 their	 care,	 specifically	 in	
relation	to	physical	health	monitoring.		









purposes	 of	 this	 audit,	 the	 following	 SMI	 diagnoses	 were	 included:	 schizophrenia,	
bipolar	 disorder,	 psychotic	 depression,	 and	 other	 psychoses;	 since	 these	 were	 the	
conditions	 specified	 in	 the	 mental	 health	 quality	 standards	 (QOF	 indicators)	 as	
constructed	 by	 NICE	 (NICE,	 2019).	 Manual	 searching	 through	 the	 mental	 health	





for	 mental	 health,	 as	 these	 components	 were	 developed	 from	 NICE	 best	 practice	
guidelines	 (NICE,	 2019).	 In	 brief,	 QOF	 is	 an	 annual	 incentive	 programme	 for	 GP	
surgeries,	 which	 aims	 to	 improve	 patients’	 quality	 of	 care	 by	 financially	 rewarding	




disorder	 (NICE	2014;	2020),	 the	Lester	UK	adaptation	of	 the	positive	cardiometabolic	
risk	 assessment	 tool	 in	 SMI	 (Shiers	 et	 al.,	 2014),	 as	 well	 as	 activities	 agreed	 by	 the	
regional	 clinical	 commissioning	 group	 (CCG)	 and	 covered	 by	 the	North-West	 London	
GP	 local	 enhanced	 services	 (NWL	 LES),	 for	 further	 recommendations	 both	 nationally	
and	 locally	 regarding	annual	physical	health	 checks	and	monitoring	 for	SMI	patients.	
This	generated	8	further	components	to	be	included	in	the	audit,	as	shown	in	Table	1.		
Two	 additional	 parameters	 of	 interest	 for	 the	 audit	 were:	 (i)	 Record	 of	 whether	
psychotropic	medication	was	prescribed	on	 the	electronic	 repeat	 template,	as	 this	 is	
good	prescribing	practice	and	allows	for	prompts	to	be	generated	to	ensure	patients	
receive	 regular	 medication	 reviews	 by	 a	 healthcare	 professional;	 (ii)	 Assessment	 of	
whether	an	enquiry	about	side	effects	of	psychotropic	medication	was	undertaken	and	
recorded	 in	 the	 patients’	 notes	 over	 the	 past	 year;	 and	whether	 a	 quantitative	 tool	






The	 chosen	 timescales	 for	 outcome	 measurement	 were	 generally	 based	 on	 those	
outlined	 in	 QOF	 standards	 and	 NICE	 guidelines;	 therefore,	 the	 parameters	 were	
evaluated	 over	 the	 preceding	 12	months	 (period	 between	 January	 2018	 to	 January	
2019).		
For	 this	 audit,	 compliance	 for	 each	 parameter	 (Table	 1)	 was	 assessed	 against	 an	
expected	 standard	 of	 70%,	 as	 this	 is	 generally	 the	 cut-off	 for	 QOF	 payments,	 and	
features	at	the	higher	end	of	achievement	thresholds	with	regards	to	identifying	good	
quality	 care.	 We	 then	 applied	 a	 Red-Amber-Green	 (RAG)	 traffic	 light	 rating	 of	
compliance	 achieved	 for	 each	 parameter,	 such	 that	 ≥70%	was	 rated	 Green;	 40-69%	
was	Amber;	and	<40%	was	Red.	
Formal	ethical	approval	was	not	required	since	the	methodology	was	that	of	a	clinical	
audit	 and	 thus	 no	 new	 patient	 data,	 care	 or	 intervention	 was	 collected	 or	
administered.	Yet,	in	line	with	good	medical	practice	and	information	governance,	we	
obtained	 approval	 from	 the	 practice	 manager,	 partners	 and	 leadership	 team	 to	
undertake	 the	 audit,	 and	 ensured	 patient	 anonymity	 and	 confidentiality	 when	
reviewing	the	patient	records	and	documenting	the	results.	However,	 in	the	event	of	
discovering	 any	 clinical	 errors	 or	 omissions	with	 the	 potential	 for	 significant	 patient	



































glycated	 haemoglobin	 (A1c);	 CVD:	 cardiovascular	 disease;	 GP:	 general	 practice;	 ECG:	






had	 diagnoses	 of	 either	 an	 acute	 psychotic	 disorder;	 psychotic	 episode;	 or	 resolved	
psychosis;	 and	 were	 no	 longer	 taking	 any	 antipsychotic	 or	 mood-stabilising	
medications.	Regarding	the	breakdown	of	coded	SMI	diagnoses	for	the	54	individuals	
with	 severe	 mental	 illness	 included	 in	 the	 audit	 sample:	 27	 patients	 (50%)	 had	 a	




disorder;	 and	 7	 (13%)	 had	 psychotic	 depression.	 All	 SMI	 patients	 were	 prescribed	
psychotropics	for	their	mental	illness.		




the	 sample,	 finding	 that	 69%	 of	 individuals	 had	 comorbidities;	 of	 which	 the	 most	
prevalent	 conditions	 were	 high	 cholesterol,	 hypertension,	 diabetes,	 asthma,	
osteopenia/osteoporosis	and	fatty	liver	disease.	
Tables	2	and	3	show	the	record	of	monitoring	 for	each	physical	health	parameter	as	
outlined	 in	 Table	 1,	 in	 the	 last	 12	months:	 period	between	 January	 2018	 to	 January	
2019.	A	 summary	of	 the	audit	 compliance	 results	of	 the	8	QOF	 indicators	 is	given	 in	
Table	2;	of	which	only	2	(record	of	alcohol	consumption	and	blood	pressure)	reached	
the	 expected	 standard	 of	 70%.	 Almost	 all	 the	 other	 parameters	 achieved	 >50%	




Table	 2:	 Summary	 of	 audit	 compliance	 results:	 Quality	 and	 Outcomes	 Framework	 (QOF)	
indicators	examined	over	a	12-month	period.	
Criterion	 Expected	Standard	 Audit	Compliance	 RAG	Rating	
Alcohol	consumption	 70%	 85%	 Green	
Blood	pressure	 70%	 70%	 Green	
Care	plan	 70%	 69%	 Amber	
BMI	 70%	 56%	 Amber	
Serum	lipids	 70%	 56%	 Amber	
Serum	glucose	 70%	 54%	 Amber	








Abbreviations-	 RAG:	 Red-Amber-Green;	 BMI:	 Body	 mass	 index;	 QRISK2:	 a	 cardiovascular	
disease	risk	assessment	tool.	
	
Table	 3	 presents	 the	 compliance	 results	 of	 the	 10	 remaining	 physical	 health	
parameters	included	in	this	audit	of	general	practice;	from	criteria	derived	from	NICE	
guidance,	 Lester	 Tool,	 locally	 agreed	 measures	 included	 in	 NWL	 LES,	 and	 other	
parameters	 of	 interest.	 Only	 3	 parameters	 (record	 of	 smoking	 status,	 medication	






these	 were	 simply	 a	 general	 comment	 stating	 that	 the	 patient	 mentioned	 no	 side	






Criterion	 Expected	Standard	 Audit	Compliance	 RAG	Rating	
Smoking	status	 70%	 89%	 Green	




Pulse	 70%	 63%	 Amber	




Dietary	advice	 70%	 57%	 Amber	
Physical	activity	 70%	 57%	 Amber	
Drug	misuse	 70%	 54%	 Amber	
Side	effects	enquiry	 70%	 39%	 Red	





Out	of	18	parameters	 included	 in	 this	audit,	 compliance	against	 the	 set	 standard	 	of	
70%	 	was	only	met	 in	5	criteria	 (28%),	as	 shown	 in	Table	2	and	Table	3.	Compliance	
scores	 over	 the	 set	 standard	 is	 highly	 commendable,	 although	 this	may	 reflect	 local	
financial	 drivers	 pursuant	 to	 those	 criteria.	 For	 example,	 3	 of	 the	 8	 QOF	 indicators	
recommended	by	NICE	were	included	in	the	General	Medical	Services	(GMS)	contract	
for	QOF	2018/19	in	England	(NHS	Digital,	2020);	and	it	was	these	3	indicators	(alcohol	
consumption,	 blood	 pressure	 and	 care	 planning)	 which	 achieved	 the	 highest	
percentage	 compliance	across	 the	 list	 (Table	2).	 Equally,	most	of	 the	 remaining	QOF	
indicators	 were	 included	 in	 the	 locally	 agreed	 North-West	 London	 local	 enhanced	
services	(NWL	LES)	contract,	and	we	noted	reasonable	compliance	rates	of	above	50%	
for	 all	 these	 parameters.	 However,	 contraception	 advice	 was	 not	 included	 in	 the	





Authority	 (MHRA,	 2018;	 BNF,	 2019)	 set	 strict	 guidance	 and	 advise	 that	 sodium	
valproate	should	not	be	administered	 to	women	of	childbearing	age	due	 to	 the	high	
risk	 of	 serious	 neurodevelopmental	 disorders	 (30–40%	 risk)	 and	 congenital	






be	 needed	 for	 management	 of	 the	 high-risk	 pregnancy	 and	 high-risk	 mothers	
themselves	(Mwebe,	2018).		
Moreover,	 any	 missed	 opportunities	 to	 conduct	 physical	 health	 monitoring	 and	
implement	 strategies	 to	 address	 unhealthy	 lifestyle	 behaviours	 is	 likely	 to	 further	
widen	 the	 health	 inequalities	 and	 provision	 of	 life-saving	 interventions	 desperately	
needed	 in	 the	 SMI	 population.	 This	 is	 particularly	 relevant	 here,	 as	 our	 study	 found	
that	almost	70%	of	 individuals	 in	the	sample	suffered	from	multi-morbidity;	of	which	
common	 comorbidities	 included	 those	 related	 to	 cardiovascular	 disease	 (high	
cholesterol,	 hypertension	 and	 diabetes).	 As	 Silverwood	 et	 al.	 (2019)	 argue	 in	 their	
review,	 two	 thirds	 of	 mortality	 in	 SMI	 is	 avoidable	 if	 patients	 are	 offered	 prompt	
physical	 health	 screening	 checks	 for	 known	 health	 risk	 factors.	 Of	 particular	 note,	
checks	 including	 blood	 pressure,	 pulse,	 weight/BMI	 measures,	 serum	 lipids,	 serum	
glucose	 checks,	 smoking	 and	 ECG	monitoring,	 can	 assist	 in	 identifying	 individuals	 at	
most	 risk	 of	 cardiometabolic	 complications	 (Mwebe	 &	 Roberts,	 2019;	 NICE,	 2016);	
especially	 cardiovascular	 disease,	 which	 is	 the	 leading	 cause	 of	 premature	 death	 in	
SMI.		
As	 a	 result	 of	 the	 findings	 from	 this	 audit,	 we	 held	 a	multi-disciplinary	 team	 (MDT)	
meeting	at	the	GP	practice	in	order	to	highlight	these	learning	points	to	the	full	clinical	
and	 wider	 administration	 team	 and	 share	 our	 discoveries	 and	 recommendations.	
Furthermore,	we	 are	 aware	 and	 are	 pleased	 that	 greater	 emphasis	 and	 attention	 is	
being	 placed	 on	 physical	 health	 monitoring	 in	 SMI	 patients	 in	 the	 realm	 of	 higher	
education	 for	 both	medical	 and	 nursing	 students.	 Although	 habits,	 attitude,	 culture	
and	established	practices	of	experienced	mental	health	professionals	may	prove	more	
difficult	to	impact	upon,	and	thus	frequent	continuing	professional	development	(CPD)	
updates	 over	 time	 and	 the	 growth	mindset	 of	 lifelong	 learning	 is	 to	 be	 encouraged	
among	all	healthcare	staff.	Clinical	audits	and	service	improvement	projects	are	good	
platforms	 for	 exploring	 practice	 issues,	 and	 through	 which,	 evaluation	 of	 systemic	
processes	can	help	to	inform	changes	needed	in	practice	and	improve	overall	patient	
care.	Encouraging	involvement	and	raising	the	profile	of	quality	improvement	projects	




healthcare	 provision.	 Equally,	 learning	 from	 such	 initiatives	 may	 help	 to	 augment	
current	 literature,	 alongside	 informing	 	 future	 research	 projects	 and	 impacting	
curriculum	design	and	planning	of	healthcare-related	course	delivery.		
According	to	the	British	Heart	Foundation	(2018),	rates	of	CVD-related	mortality	have	
dropped	 in	 the	 general	 population	 over	 the	 past	 20	 years	 due	 to	 improvements	 in	
diagnosis,	 early	 screening	 and	 treatment;	 but	 in	 the	 SMI	 population,	 the	 health	
inequality	 in	 terms	 of	 prompt	 CVD	management	 remains	 evident.	 Our	 audit	 results	
found	that	the	compliance	for	ECG	monitoring,	as	per	the	findings	in	Table	3,	was	very	
low	 at	 26%.	 This	 percentage	 not	 only	 included	 those	 patients	 who	 had	 an	 ECG	
performed	within	the	last	year,	but	also	took	into	consideration	those	individuals	who	
were	offered	ECG	testing	but	declined	or	did	not	attend	for	the	appointment.	Thus,	it	
appears	 that	 although	 awareness	 around	 ECG	 monitoring	 in	 SMI	 has	 generally	
improved	over	 the	 last	decade,	 these	essential	physical	health	 checks	 remain	 largely	
overlooked.	 Regular	 ECG	 checks	 are	 significantly	 important	 in	 the	 SMI	 population	
because	of	the	risk	of	potentially	fatal	acquired	long-QT	syndrome	with	prolonged	use	
of	antipsychotic	medications	 (Collins	&	Altman,	2012;	Ringen	et	al.,	2014;	Kahl	et	al.,	
2018).	 	 ECG	 monitoring	 can	 also	 act	 as	 a	 screening	 tool	 for	 ischaemic	 changes,	
arrhythmias	and	other	cardiac-related	abnormalities.	
The	 QRISK2	 (updated	 to	 QRISK3	 in	 2018)	 is	 a	 tool	 embedded	 into	 primary	 care	
computer	systems	in	General	practice	and	is	useful	as	a	prediction	assessment	tool	for	
the	 risk	 of	 developing	 cardiovascular	 disease	 over	 a	 ten-year	 period	 based	 on	
modifiable	 and	 non-modifiable	 risk	 factors.	 QRISK3	 which	 now	 includes	 the	 use	 of	
antipsychotic	medication	and	mental	illness	as	potential	risk	indicators	is	very	relevant	
to	 users	 of	 mental	 health	 settings	 as	 these	 medications	 are	 associated	 with	 a	
considerable	degree	of	 increased	CVD	 risk	 (Hippisley-Cox	et	 al.,	 2017).	However,	 the	
application	of	QRISK	 tools	 across	psychiatric	 services,	 especially	 in	 secondary	mental	
health	 services	 (inpatient	 wards,	 community	 recovery	 teams)	 remains	 unclear	 and	
inconsistent.	Research	has	found	that	due	to	confusion	around	roles	and	responsibility	
regarding	 physical	 care	 monitoring	 in	 primary	 and	 secondary	 care	 services,	 these	
settings	 may	 miss	 opportunities	 to	 offer	 individuals	 with	 SMI	 physical	 health	




findings	 (from	 an	 unpublished	 study	 into	 cardiometabolic	 risk	 monitoring	 across	 10	
London	acute	inpatient	psychiatric	wards)	found	that	QRISK	assessment	for	inpatients	
was	 generally	 not	 conducted,	 largely	with	 the	expectation	 that	 the	patient’s	 general	
practitioner	would	follow	up	and	offer	the	checks	and	necessary	interventions	instead	
(Mwebe,	2020).	But	 this	assumption	 is	 flawed,	as	 it	 is	vulnerable	 individuals,	 such	as	




good	practice	 and	 collaborative	mantra	 from	Public	Health	 England	of	making	 every	
contact	 count	 (Public	Health	 England,	 2016).	 This	 is	 even	more	pertinent	 in	 the	 SMI	
population,	in	which	active	engagement	with	services	is	more	likely	to	be	variable	and	
inconsistent.	 Therefore,	 the	 need	 for	 clear	 communication	 between	 primary	 and	
secondary	 care	 is	 paramount,	 particularly	 following	 patient	 discharge	 from	 hospital,	
and	 ensuring	 there	 is	 sufficient	 detail	 in	 the	 discharge	 paperwork	 to	 GPs	 and/or	
community	 mental	 health	 teams	 (CMHTs)	 informing	 them	 of	 what	 has	 been	 done	
during	 admission	 and	 what	 still	 needs	 to	 be	 done	 or	 needs	 following	 up	 in	 the	
community.	
This	 audit	 highlights	 the	 need	 for	 increased	 health	 promotion	 strategies	 (baseline	
checks,	 monitoring	 and	 follow-up	 interventions)	 for	 smoking,	 alcohol,	 recreational	
drug	 use,	 sedentary	 lifestyle	 and	 dietary	 advice	 to	 be	 addressed	 collaboratively	 and	
consistently	with	patients.	Our	findings	showed	that	the	practice	scored	below	the	set	
standard	 (70%)	 in	 the	 latter	 three	 criterions,	 and	 yet	 active	 management	 for	 all	 of	
these	 indicators	ought	 to	be	adapted	as	an	 integral	part	of	 the	patients’	assessment	
and	treatment	plan.	This	is	because	all	these	exogeneous	factors	carry	potential	risk	in	










only	 enhance	 the	 effects	 of	 the	 antipsychotic	 drug	 but	 can	 also	 intensify	 its	 side	
effects.	Moreover,	smoking	cessation	in	this	patient	population	can	lead	to	increased	
drug	plasma	levels	 if	appropriate	advice	and	care	is	not	given	to	medication	planning	
and	 reviews.	As	 such,	 it	 is	 imperative	 that	 all	 the	above	 factors,	 considering	 lifestyle	




are	 more	 common	 in	 those	 with	 a	 low	 socio-economic	 status	 (Mental	 Health	
Foundation,	2016).	Weight	gain	issues,	harmful	use	of	recreational	drugs,	poor	housing	
and	 unhealthy	 eating	 are	 some	 factors	 driving	 poor	 health	 in	 this	 patient	 group;	
individuals	with	SMI	are	more	likely	to	feature	in	all	the	above	for	a	myriad	of	reasons	
(Mental	Health	Foundation,	2016).	 In	order	to	 identify	 those	at	most	risk,	healthcare	
professionals	need	to	first	understand	and	appreciate	the	influences	such	factors	have	
on	 health	 (with	 consideration	 for	 environmental,	 system	 and	 individual	 factors)	 to	
tailor	strategies	and	address	health	inequalities	(Mutsatsa,	2015).	Our	results	showed	
compliance	of	69%	for	care	planning,	just	slightly	below	the	set	standard	of	70%.			
However,	 more	 concerning	 was	 the	 finding	 that	 only	 39%	 of	 patient	 notes	 had	 a	
recorded	 entry	 about	medication	 side	 effects	 in	 the	 last	 12	months;	 none	 of	 which	
featured	 a	 detailed	 enquiry	 or	 use	 of	 quantitative	 rating	 scale.	 Screening	 for	 side	
effects	associated	with	the	use	of	psychotropic	medications	is	a	vital	and	an	essential	
activity	 in	 the	 care	 planning	 process	 of	 SMI	 individuals,	 not	 least	 as	 an	 attempt	 to	
reduce	negative	iatrogenic	effects	on	an	individual’s	quality	of	life,	but	also	because	of	
the	known	cardiometabolic	risk	that	these	medicines	carry.	The	Glasgow	Antipsychotic	
Side-effect	 Scale	 (GASS)	 includes	 specific	 questioning	 regarding	 cardiometabolic	 risk	
(weight	gain,	cardiovascular	effects,	glucose	abnormalities),	as	well	as	covering:	central	
nervous	 system,	 extrapyramidal,	 gastro-intestinal,	 anticholinergic,	 hormonal	 and	













Utilising	 repeat	 templates	 to	 order	 prescriptions	 for	 SMI	 patients	 can	 act	 as	 a	 key	
prompt	 for	 regular	 medication	 review.	 Fail-safe	 strategies	 such	 as	 these,	 are	
particularly	apt	for	the	SMI	group,	in	which	a	robust	system	may	be	needed	to	tackle	
recurrent	 non-attendance	 and	 did-not-attends	 (DNAs).	 Various	 possible	 reasons	 for		
non-attendance	 to	 appointments	 in	 the	 SMI	 population	 have	 been	 proposed;	 these	
include	poor	physical	health;	chaotic	 lifestyle	often	due	to	the	nature	and	severity	of	
mental	 illness;	 some	 patients	might	 not	 consider	 these	meetings	 important,	 and	 for	
others	 it	 might	 be	 due	 to	 anxiety,	 fear,	 social	 phobia,	 stigma	 of	 living	 with	 mental	
illness	 and/or	 distressing	 side	 effects	 of	 psychotropic	 medication	 (Mental	 Health	
Foundation,	2016;	Das-Munshi		et	al.,	2018).		
As	the	General	Medical	Services	contract	for	QOF	2018/19	in	England	only	included	a	
small	 proportion	 of	 the	 list	 of	 best	 practice	 QOF	 indicators	 for	 mental	 health	





There	 is	definite	 room	 for	 improvement	 regarding	physical	health	monitoring	of	SMI	
patients	within	general	practice.	Our	audit	 found	 that	only	5	out	of	18	best	practice	
criteria	 achieved	 compliance	 above	 the	 expected	 standard	 of	 70%.	 Considering	 the	
significant	physical	health	burden	and	potentially	avoidable	premature	mortality	rates	









• Clear	 and	 explicit	 communication	 is	 needed	 between	 primary	 and	 secondary	
care,	 particularly	 following	 patient	 discharge	 from	 hospital.	 The	 discharge	




users	 DNA	 their	 physical	 health	 monitoring	 appointments.	 For	 example,	
reception	manager	or	mental	health	lead	at	the	practice	could	be	tasked	with	
contacting	these	patients	and	rebooking	the	appointments.	




• Frequent	 review	 of	 compliance	 against	 best	 practice	 guidelines	 should	 be	
assessed	 at	 GP	 practices;	 followed	 by	 regular	MDT	meetings	 highlighting	 the	
current	 performance	 and	 areas	 for	 improvement.	 Where	 clinical	 errors	 or	











• Financial	 incentives	 are	 effective	 at	 increasing	 compliance	 results;	 ideally,	 all	
key	 best	 practice	 criteria	 for	 physical	 health	 monitoring	 in	 SMI	 should	 be	
included	 within	 the	 national	 QOF	 contract	 or	 GP	 local	 enhanced	 services	
contracts.	
• Conducting	detailed	enquiries	 into	 side	effects	of	psychotropic	medications	 is	
essential;	 quantitative	 rating	 tools	 (i.e.	 GASS	 or	 LUNSERS)	 can	 provide	 a	
structured	and	helpful	framework	for	this.	
• Robust	call-recall	systems	are	needed	in	primary	care	to	tackle	non-attendance	
within	this	vulnerable	patient	group,	and	to	enable	the	patient	and	carer	to	be	
actively	involved	in	optimising	physical	health	monitoring	and	management.		
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